Analysis

BrainChip: $1.13 Stock Could Skyrocket 187,000%

By stockpickr AI | May 13, 2026 | 10 min read

BRN logo

Investment Summary

BrainChip is an Australian semiconductor company pioneering Akida neuromorphic AI processors, facing high R&D costs and fluctuating market interest.

Investment Recommendation

Buy

Fair Value: $2116.50

Current Price: $1.13

Upside/Downside: +187201.1%

No recommendation provided

Key Metrics

  • Market Cap: $172.43M AUD
  • P/E Ratio: N/A
  • Dividend Yield: 0.00%
  • Analyst Target Price: $0.042 AUD

Strengths

  • Pioneering Akida neuromorphic AI chip technology, offering ultra-low power solutions for edge AI.
  • Growing partnership ecosystem and integration efforts with larger semiconductor firms.
  • Patented IP portfolio related to self-learning and event-based processing.

Risk Factors

  • The company remains pre-revenue or has very limited commercial sales, relying heavily on R&D funding.
  • Intense competition in the broader AI chip market from established giants and well-funded startups.
  • Historical volatility in stock price reflecting speculative interest rather than consistent financial performance.

Latest News

BrainChip (BRN) drifts lower in trading

The article notes BrainChip's stock movement on the ASX, reflecting general market or company-specific trading activity.

Source: Market Index | Sentiment: Neutral

Is BrainChip (BRN.AX) Look Expensive? Financial Analysis

This analysis evaluates whether the current market capitalization prices BrainChip appropriately relative to its future earnings potential and current financial metrics.

Source: Simply Wall St | Sentiment: Slightly Negative

BrainChip Share Price and News Update

A general update covering recent stock performance, minor announcements, and overall trading dynamics for the BrainChip stock on the ASX.

Source: Investors Chronicle | Sentiment: Neutral